MIR6793

Across TCGA pan-cancer cohorts, MIR6793 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR6793 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR6793 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6793 expression acts as an unfavorable survival marker, although some lineages such as GBM and KIRP show a favorable association.

KICH, LUSC, and GBM are the cancer types where MIR6793 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Quartile	III,IV	0.159	0.856	<.001	74	view →
LUSC	OS	Tertile	IV	0.057	0.852	.017	36	view →
GBM	DFS	Quartile	All	0.466	0.223	.010	29	view →
LUAD	OS	Median	IV	0.279	0.730	.012	26	view →
KIRP	DFS	Tertile	II,III,IV	0.805	0.389	.005	24	view →
THCA	DFS	Tertile	II,III,IV	0.249	0.785	.025	21	view →
UCEC	OS	Quartile	All	0.553	0.722	.006	20	view →
LAML	DFS	Tertile	All	0.868	0.427	<.001	18	view →
UCS	OS	Tertile	IV	0.844	0.250	.016	18	view →
LGG	DFS	Tertile	All	0.774	0.862	.007	17	view →
CHOL	DFS	Median	All	0.689	0.183	.003	14	view →
COAD	DFS	Median	II,III,IV	0.262	0.619	.006	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR6793–KICH (OS)

Open the KICH breakdown →